Candriam SCA’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,205
| Closed | -$405K | – | 725 |
|
|
2023
Q1 | $405K | Buy |
+20,205
| New | +$405K | ﹤0.01% | 822 |
|
|
2020
Q2 | – | Sell |
-115,000
| Closed | -$1.83M | – | 802 |
|
|
2020
Q1 | $1.83M | Hold |
115,000
| – | – | 0.02% | 543 |
|
|
2019
Q4 | $1.87M | Buy |
115,000
+65,000
| +130% | +$1.06M | 0.02% | 559 |
|
|
2019
Q3 | $1.75M | Sell |
50,000
-20,000
| -29% | -$700K | 0.02% | 518 |
|
|
2019
Q2 | $3.93M | Hold |
70,000
| – | – | 0.05% | 382 |
|
|
2019
Q1 | $5.11M | Hold |
70,000
| – | – | 0.07% | 321 |
|
|
2018
Q4 | $4.47M | Hold |
70,000
| – | – | 0.07% | 303 |
|
|
2018
Q3 | $6.98M | Buy |
70,000
+35,900
| +105% | +$3.58M | 0.09% | 253 |
|
|
2018
Q2 | $2.42M | Buy |
34,100
+7,100
| +26% | +$504K | 0.04% | 443 |
|
|
2018
Q1 | $2.81M | Sell |
27,000
-12,500
| -32% | -$1.3M | 0.05% | 406 |
|
|
2017
Q4 | $3.98M | Buy |
+39,500
| New | +$3.98M | 0.07% | 315 |
|